OnKure Therapeutics, Inc.: shareholders and insiders

OKURNASDAQHealthcare · Pharmaceutical Preparations

Price

$2.70

November 20, 2026Market cap $111M

What Ploutos Investor adds for OnKure Therapeutics

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 2 fiscal years, from 2024
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Insiders and their shares

Purchases and sales by officers and directors, from their own Form 4 filings.

Reading the newest filings from the SEC. This part fills in on its own in a few seconds.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

10 Holders over 5%1 On a 13DOct 7, 2026 Latest filing
  • AI Biotechnology LLCwith 3 more personsClass A Common Stock, par value $0.0001 per share
    Share of class20.0%
  • RA Capital Management, L.P.with 3 more personsClass A Common Stock, $0.0001 par value per share
    Share of class9.90%
  • Acorn Bioventureswith 4 more persons
    Share of class9.50%
  • Biotechnology Value Fund L Pwith 9 more personsClass A Common Stock, par value $0.0001 per share
    Share of class8.00%
  • Coastlands Capital LPwith 4 more personsClass A Common Stock, par value $0.0001 per share
    Share of class6.67%
  • StepStone Group LPwith 2 more personsClass A Common Stock, par value $0.0001 per share
    Share of class6.60%
  • Shay Capital LLCwith 1 more personClass A Common Stock, par value $0.0001 per share
    Share of class6.30%
  • Trails Edge Capital Partners, LPwith 2 more personsClass A Common Stock, $0.0001 par value per share
    Share of class6.00%
  • ADAR1 Capital Management, LLCwith 2 more personsClass A Common Stock, par value $0.0001 per share
    Share of class5.50%
  • Cantor Fitzgerald Securitieswith 3 more personsClass A Common Stock, par value $0.0001 per share
    Share of class5.20%

What the holders on a 13D state as their purpose

From Item 4 of the filing, in the holder's own words. It is the intention the holder states, not something that happened.

  • AI Biotechnology LLC20.0%From the filing of Apr 7, 2026

    The information set forth in Item 3 and Item 6 hereof is hereby incorporated herein by reference. The Reporting Persons who hold securities of the Issuer directly acquired those securities as an investment in the regular course of their businesses. The Reporting Persons may engage in discussions with management, the Issuer's board of directors, other stockholders of the Issuer and other relevant parties concerning the business, operations, board composition, management, strategy and future plans of the Issuer. Dr. Liam Ratcliffe, who is currently employed by Access Industries, Inc., an affiliate of AIB, as its Head of Biotechnology, serves on the board of directors of the Issuer (in…

    From the filing of Apr 7, 2026
Fell to 5% or less (11)

Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.

  • Trails Edge Capital Partners, LP3.60%Aug 14, 202613G/A
  • Prosight Management, LP2.40%Aug 10, 202613G/A
  • Highbridge Capital Management, LLC4.20%Feb 17, 202613G/A
  • Citadel Advisors LLC1.70%Feb 17, 202613G/A
  • The Vanguard Group4.87%Jan 30, 202613G/A
  • Perceptive Advisors LLC0.00%Aug 14, 202513G/A
  • Samsara BioCapital, L.P.0.00%Aug 14, 202513G/A
  • Cormorant Asset Management, LP0.00%May 19, 202513G/A
  • Deep Track Capital, LP4.14%Feb 14, 202513G/A
  • Lundbeckfond Invest A/S1.60%Feb 6, 202513G/A
  • RiverVest Venture Fund III, L.P.13D1.55%Jan 21, 202513D/A

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • Citadel Advisors (Griffin)
    In the quarter-53%
  • Renaissance Technologies
    In the quarter-1.6%

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 3.38% of its shares outstanding were held short, +13.2% since the report before.

Shares held short
1.39M
3.38%
Since the report before1.22M on Sep 30, 2026
+13.2%
2.6
543.5K
More days to cover thanof 4,578 US-listed companies with enough volume
30%
Report date
Oct 15, 2026
  • Oct 15, 2024: Shares held short 693.8K
  • Oct 31, 2024: Shares held short 924.6K
  • Nov 15, 2024: Shares held short 1.02M
  • Nov 29, 2024: Shares held short 1.12M
  • Dec 13, 2024: Shares held short 1.24M
  • Dec 31, 2024: Shares held short 1.24M
  • Jan 15, 2025: Shares held short 1.41M
  • Jan 31, 2025: Shares held short 1.40M
  • Feb 14, 2025: Shares held short 1.10M
  • Feb 28, 2025: Shares held short 1.10M
  • Mar 14, 2025: Shares held short 1.07M
  • Mar 31, 2025: Shares held short 1.06M
  • Apr 15, 2025: Shares held short 1.15M
  • Apr 30, 2025: Shares held short 574.0K
  • May 15, 2025: Shares held short 560.2K
  • May 30, 2025: Shares held short 530.3K
  • Jun 13, 2025: Shares held short 512.9K
  • Jun 30, 2025: Shares held short 351.2K
  • Jul 15, 2025: Shares held short 244.4K
  • Jul 31, 2025: Shares held short 225.9K
  • Aug 15, 2025: Shares held short 228.9K
  • Aug 29, 2025: Shares held short 197.9K
  • Sep 15, 2025: Shares held short 193.2K
  • Sep 30, 2025: Shares held short 174.6K
  • Oct 15, 2025: Shares held short 65.1K
  • Oct 31, 2025: Shares held short 48.4K
  • Nov 14, 2025: Shares held short 37.7K
  • Nov 28, 2025: Shares held short 41.4K
  • Dec 15, 2025: Shares held short 52.0K
  • Dec 31, 2025: Shares held short 24.4K
  • Jan 15, 2026: Shares held short 9,877
  • Jan 30, 2026: Shares held short 14.2K
  • Feb 13, 2026: Shares held short 33.4K
  • Feb 27, 2026: Shares held short 53.8K
  • Mar 13, 2026: Shares held short 7,962
  • Mar 31, 2026: Shares held short 163.9K
  • Apr 15, 2026: Shares held short 69.5K
  • Apr 30, 2026: Shares held short 103.4K
  • May 15, 2026: Shares held short 199.4K
  • May 29, 2026: Shares held short 234.9K
  • Jun 15, 2026: Shares held short 282.4K
  • Jun 30, 2026: Shares held short 878.7K
  • Jul 15, 2026: Shares held short 1.18M
  • Jul 31, 2026: Shares held short 1.19M
  • Aug 14, 2026: Shares held short 1.07M
  • Aug 31, 2026: Shares held short 1.32M
  • Sep 15, 2026: Shares held short 1.38M
  • Sep 30, 2026: Shares held short 1.22M
  • Oct 15, 2026: Shares held short 1.39M

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading23.2% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 23.2% of the shares in the reported trades were short sales, against 61.9% in the 14 before.

Last 14 sessionsNov 3, 2026 – Nov 20, 2026
23.2%
The 14 beforeOct 14, 2026 – Nov 2, 2026
61.9%
Change
-38.7 pts
Short sales a dayon average, of 242.3K shares
56.2K
More than atof 3,666 US-listed companies, same days
1%
Median of alleight in ten from 34.4% to 63.9%
50.5%
  • Oct 14, 2026: Short sales 85.2%
  • Oct 15, 2026: Short sales 75%
  • Oct 16, 2026: Short sales 47.4%
  • Oct 19, 2026: Short sales 65.2%
  • Oct 20, 2026: Short sales 51.2%
  • Oct 21, 2026: Short sales 64.4%
  • Oct 22, 2026: Short sales 52.5%
  • Oct 23, 2026: Short sales 56.2%
  • Oct 26, 2026: Short sales 59.9%
  • Oct 27, 2026: Short sales 78.9%
  • Oct 28, 2026: Short sales 53.8%
  • Oct 29, 2026: Short sales 31.2%
  • Oct 30, 2026: Short sales 90.1%
  • Nov 2, 2026: Short sales 74.7%
  • Nov 3, 2026: Short sales 90.2%
  • Nov 4, 2026: Short sales 3.9%
  • Nov 5, 2026: Short sales 14.2%
  • Nov 6, 2026: Short sales 27.8%
  • Nov 9, 2026: Short sales 22.6%
  • Nov 10, 2026: Short sales 62.1%
  • Nov 11, 2026: Short sales 49.5%
  • Nov 12, 2026: Short sales 73.3%
  • Nov 13, 2026: Short sales 14.4%
  • Nov 16, 2026: Short sales 11.6%
  • Nov 17, 2026: Short sales 61.2%
  • Nov 18, 2026: Short sales 80%
  • Nov 19, 2026: Short sales 78.3%
  • Nov 20, 2026: Short sales 65.5%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

The ETFs that hold it

Which of the 349 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

7 ETFs holding it0.02% The largest weight (IWC)
  • IWCiShares Micro-Cap ETF
    Weight in the fund0.02%
  • IWNiShares Russell 2000 Value ETF
    Weight in the fund0.01%
  • VTWOVanguard Russell 2000 Index Fund
    Weight in the fund0.00%
  • IWMiShares Russell 2000 ETF
    Weight in the fund0.00%
  • VXFVanguard Extended Market Index Fund
    Weight in the fund0.00%
  • DFASDimensional U.S. Small Cap ETF
    Weight in the fund0.00%
  • VTIVanguard Total Stock Market Index Fund
    Weight in the fund0.00%

7 of the 349 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

75 Managers, Q2 2026$159M Value of their positions
  • Q3 2025: Managers 42
  • Q4 2025: Managers 43
  • Q1 2026: Managers 52
  • Q2 2026: Managers 75

Institutional investors by quarter

The fund managers holding OKUR, quarter by quarter, from Q3 2024 to Q2 2025, 4 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 8 quarters.

Q2 2026: 75 managers held 34.97M shares, worth $159M. During the quarter 31 opened a position, 8 closed one, 20 added and 9 trimmed.

The largest holders, Q2 2026

  • Ra Capital Management
    In the quarter
  • Bvf
    In the quarter+64%
  • Acorn Capital Advisors
    In the quarter
  • StepStone Group
    In the quarter
  • ADAR1 Capital Management
    In the quarter-8.1%
  • Vivo Capital
    In the quarter
  • Vestal Point Capital
    In the quarter-0.8%
  • BlackRock
    In the quarter×30.2
  • Trails Edge Capital Partners
    In the quarter
  • Vanguard Capital Management
    In the quarter+147%

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do OnKure Therapeutics's filings show?

Who buys and sells is one part of OnKure Therapeutics's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about OKUR's shareholders

Didn't find what you were looking for?

Ask us
Which well-known managers hold OKUR?

2 of the managers we track held the shares on Sep 30, 2026. The largest position was Citadel Advisors (Griffin)'s, worth $1.5M.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.